31 October, 2024TechBio startup Cure51 selects 10x Genomics Visium HD for new drug discovery initiative
30 October, 2024Noema Pharma announces first patients dosed in Phase 2b study with Gemlapodect (NOE-105), a first-in-class investigational therapy for Tourette Syndrome
28 October, 2024AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)
24 October, 2024deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI
23 October, 2024Bioptimus and Proscia collaborate to accelerate AI innovation in scientific research and drug development for improved patient care